Abstract:Cardiac arrhythmias cause significant morbidity and mortality and pose a major public health problem. They arise from disruptions in the normally orderly propagation of cardiac electrophysiological activation and recovery through successive cardiomyocytes in the heart. They reflect abnormalities in automaticity, initiation, conduction, or recovery in cardiomyocyte excitation. The latter properties are dependent on surface membrane electrophysiological mechanisms underlying the cardiac action potential. Their disruption results from spatial or temporal instabilities and heterogeneities in the generation and propagation of cellular excitation. These arise from abnormal function in their underlying surface membrane, ion channels, and transporters, as well as the interactions between them. The latter, in turn, form common regulatory targets for the hierarchical network of diverse signaling mechanisms reviewed here. In addition to direct molecular-level pharmacological or physiological actions on these surface membrane biomolecules, accessory, adhesion, signal transduction, and cytoskeletal anchoring proteins modify both their properties and localization. At the cellular level of excitation–contraction coupling processes, Ca 2+ homeostatic and phosphorylation processes affect channel activity and membrane excitability directly or through intermediate signaling. Systems -level autonomic cellular signaling exerts both acute channel and longer-term actions on channel expression. Further upstream intermediaries from metabolic changes modulate the channels both themselves and through modifying Ca 2+ homeostasis. Finally, longer-term organ -level inflammatory and structural changes, such as fibrotic and hypertrophic remodeling, similarly can influence all these physiological processes with potential pro-arrhythmic consequences. These normal physiological processes may target either individual or groups of ionic channel species and alter with particular pathological conditions. They are also potentially alterable by direct pharmacological action, or effects on longer-term targets modifying protein or cofactor structure, expression, or localization. Their participating specific biomolecules, often clarified in experimental genetically modified models, thus constitute potential therapeutic targets. The insights clarified by the physiological and pharmacological framework outlined here provide a basis for a recent modernized drug classification. Together, they offer a translational framework for current drug understanding. This would facilitate future mechanistically directed therapeutic advances, for which a number of examples are considered here. The latter are potentially useful for treating cardiac, in particular arrhythmic, disease.

Small-conductance calcium-activated potassium channels in the heart: expression, regulation and pathological implications

Small-conductance Ca2+-activated K+ Channels Promote J-wave Syndrome and Phase 2 Reentry

Molecular Identification and Functional Roles of a Ca2+-activated K+ Channel in Human and Mouse Hearts

Ablation of a Ca2+-activated K+ Channel (SK2 Channel) Results in Action Potential Prolongation in Atrial Myocytes and Atrial Fibrillation.

Calcium-Activated Potassium Channels: Potential Target for Cardiovascular Diseases.

Differential expression of small-conductance Ca<sup>2+</sup>-activated K<sup>+</sup>channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes

Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes.

Reduction in Cardiac Kir3.4 Channel Expression Causes Congenital Long QT Syndrome: A Functional Role of Girk Currents in Ventricular Repolarization

Molecular biology of K(+) channels and their role in cardiac arrhythmias.

The regulation of the small-conductance calcium-activated potassium current and the mechanisms of sex dimorphism in J wave syndrome

A38. Functional coupling of SK2 channel to L-type calcium channel via α-actinin2 in cardiac myocytes

Molecular biology of K+ channels and their role in cardiac arrhythmias11Am J Med. 2001;110-50-59.

Epilepsy-associated Kv1.1 channel subunits regulate intrinsic cardiac pacemaking in mice

Functional Roles Of A Ca2+-Activated K+ Channel In Atrioventricular Nodes

Atomistic mechanisms of the regulation of small-conductance Ca2+-activated K+ channel (SK2) by PIP2

Abstract 17405: Small K+ Channel Activity Modulates Sinoatrial Node Pacemaker Rate and Explains the Abnormal Bursts of Sinoatrial Node Pacing in Atrial-Specific Na+/Ca2+ Exchange Knockout Mice

Functional Roles of a Ca <sup>2+</sup> -Activated K <sup>+</sup> Channel in Atrioventricular Nodes

Structural Mechanisms for the Activation of Human Cardiac KCNQ1 Channel by Electro-Mechanical Coupling Enhancers

Cardiac arrhythmogenesis: roles of ion channels and their functional modification

Exploring the Impact of BKCa Channel Function in Cellular Membranes on Cardiac Electrical Activity

Role of voltage-gated potassium channel α subunits in cardiovascular system